Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.19.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Total revenue $ 7,008 $ 482
Operating expenses:    
Research and development 8,454 6,687
General and administrative 4,935 2,910
Total operating expenses 13,389 9,597
Loss from operations 6,381 9,115
Interest and other income, net 510 82
Interest and other expense, net (293) (295)
Change in fair value of warrant liabilities (4) 614
Net loss attributable to common shareholders $ 6,168 $ 8,714
Net loss per share attributable to common shareholders:    
Basic and diluted $ 0.17 $ 0.32
Weighted average number of shares used in net loss per share calculations:    
Basic and diluted 36,738,993 26,989,693
Net loss attributable to common shareholders $ 6,168 $ 8,714
Other comprehensive loss:    
Unrealized gain (loss) on available-for-sale securities 0 0
Comprehensive loss 6,168 8,714
Research And Development Revenue | Other    
Total revenue 0 68
Research And Development Revenue | Related Party    
Total revenue 6,413 163
Grant    
Total revenue $ 595 $ 251